<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0709222592
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2016
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PRISMASOL 4 mmol/l POTASSIUM SOLUTION FOR HAEMO/HAEMOFI
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        SODIUM CHLORIDE, CALCIUM CHLORIDE,LACTIC ACID,POTASSIUM CHLORIDE,SODIUM HYDROGEN CARBONATE,GLUCOSE,MAGNESIUM CHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        6.45,5.145,5.4,0.314,3.090,22,2.033
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        g/l
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for haemodialysis/haemofiltration
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bag
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        18
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store between (4°c – 30°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        128.8
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Bieffe Medital S.p.A" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Bieffe Medital S.p.A
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            BAXTER HOLDING B.V
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05ZB 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Prismasol contains the active substances calcium chloride dihydrate, magnesium chloride hexahydrate, glucose monohydrate, lactic acid solution 90% w/w, sodium chloride, potassium, chloride and sodium hydrogen carbonate.</p><p>&nbsp;</p><p>Prismasol is used in the treatment of renal failure as a solution for continuous haemofiltration or haemodiafiltration (as a replacement for fluid lost from the blood passing through a filter) and continuous haemodialysis or haemodiafiltration (the blood flows on one side of a dialysis membrane while a haemodialysis solution flows on the other side of the membrane).</p><p>&nbsp;</p><p>Prismasol solution may also be used in case of drug poisoning with dialysable or filterable substances.</p><p>&nbsp;</p><p>Prismasol 4 mmol/l Potassium is indicated particularly in patients who are normokalaemic (a normal concentration of potassium in the blood).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Prismasol 4 mmol/l Potassium in case of:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergy to one of the active substances or any of the other ingredients (listed in section 6),</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a high concentration of potassium in the blood (hyperkalaemia),</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a high concentration of bicarbonate in the blood (metabolic alkalosis).</p><p>&nbsp;</p><p>Presence of corn antigen in Prismasol cannot be excluded.</p><p>&nbsp;</p><p><strong>Do not use haemofiltration/ dialysis</strong> <strong>in the following cases:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Renal failure with pronounced hypercatabolism (abnormally increased catabolism), if the uraemic symptoms (symptoms caused by high concentration of urea in your blood) cannot be corrected with haemofiltration,</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Insufficient arterial pressure in the vascular access,</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Systemic anticoagulation (reduced clotting of your blood), if there is a high risk of haemorrhage (bleeding).</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor, pharmacist or nurse before using Prismasol.</p><p>The solution should be used only by, or under the direction of a doctor competent in renal failure treatments using haemofiltration, haemodiafiltration and continuous haemodialysis.</p><p>&nbsp;</p><p>Before and during treatment, your blood condition will be checked, e.g. your acid-base balance and concentrations of electrolytes (salts in the blood) will be monitored, including all fluid you are given (intravenous infusion) and that you produce (urine production), even those not directly related to the therapy.</p><p>Your blood glucose concentration should be closely monitored, especially if you are diabetic.</p><p>&nbsp;</p><p><strong>Other medicines and Prismasol</strong></p><p>Tell your doctor or pharmacist if you are given, have recently been given or might be given any other medicines.</p><p>The blood concentration of some of your other medicines may be reduced during the treatment. Your doctor will decide if your medication should be changed.</p><p>&nbsp;</p><p>In particular tell your doctor if you are using either of the following:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Digitalis medicine (for treatment of certain heart conditions) as the risk of cardiac arrhythmia (irregular or rapid beating of the heart) caused by digitalis is increased during hypokalaemia (low concentration of potassium in your blood).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vitamin D and medicinal products containing calcium, as they can increase the risk of hypercalcaemia (a high concentration of calcium in your blood).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any addition of sodium hydrogen carbonate (or other buffer source) may increase the risk of metabolic alkalosis (excess of bicarbonate in your blood).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; When citrate is used as an anticoagulant (as a protective additive in dialysis equipment), it can reduce plasma calcium levels.</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p>Your doctor will decide if you should be given Prismasol if you are pregnant or breast-feeding.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>Prismasol is not known to affect the ability to drive or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>The volume of Prismasol used will depend on your clinical condition and the target fluid balance. The dose volume is therefore at the discretion of the responsible doctor.</p><p>&nbsp;</p><p>Administration route: Intravenous use and for haemodialysis.</p><p>&nbsp;</p><p><strong>If you think you use more Prismasol than you should </strong></p><p>Your fluid balance, electrolyte and acid-base balance will be carefully monitored.</p><p>In the unlikely event that an overdose occurs, your doctor will take necessary corrective measures and adjust your dose.</p><p>Overdose may result in:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fluid overload in your blood,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; elevation of the bicarbonate blood level (metabolic alkalosis),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and/or reduction of levels of salts in the blood (hypophosphataemia, hypokalaemia).</p><p>Overdose could lead to severe consequences, such as congestive heart failure, electrolyte or acid-base disturbances.</p><p>&nbsp;</p><p>For instructions for use, please see section &ldquo;The following information is intended for healthcare professionals only&rdquo;.</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, please ask your doctor, pharmacist or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p>The following side effects have been reported:</p><p>&nbsp;</p><p>Not known: frequency cannot be estimated from the available data</p><ul><li>Changes of levels of salts in the blood (electrolyte imbalances such as hypophosphataemia)</li><li>Elevation of the plasma bicarbonate concentration (metabolic alkalosis) or reduction of the plasma bicarbonate concentration (metabolic acidosis).</li><li>Abnormally high or low volume of water in the body (hyper- or hypovolaemia)</li><li>Abnormally high concentration of glucose in the blood (hyperglycaemia)</li></ul><ul><li>Nausea</li><li>Vomiting</li><li>Muscle cramps</li><li>Hypotension (low blood pressure)</li><li>Hypercalcaemia (a high concentration of calcium in your blood).</li></ul><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.</p><p>You can also report side effects directly via the national reporting system listed below. By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p>&nbsp;</p><ul><li><strong>Saudi Arabia:</strong></li></ul><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:588px"><tbody><tr><td style="vertical-align:top"><ul><li>The National Pharmacovigilance Centre (NPC)</li></ul><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/ <u>&nbsp;</u>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:588px"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children</p><p>&nbsp;</p><p>Store between +4&deg;C and +30&deg;C.</p><p>&nbsp;</p><p>Do not use this medicine after the expiry date which is stated on the label and the packaging. The expiry date refers to the last day of that month.</p><p>Chemical and physical in-use stability of the reconstituted solution has been demonstrated for 24 hours&nbsp; at 22&deg;C. If not used immediately in-use storage times and conditions prior to use are the responsibility of the user and shall not be longer than 24 hours including the duration of the treatment.</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Prismasol contains</strong></p><p><u>&nbsp;</u></p><p><strong>The active substances are: </strong></p><p>&nbsp;</p><p><strong>Before reconstitution:</strong></p><p><strong>1000 ml of electrolyte solution (from the small compartment (A)) contains</strong></p><p>Calcium chloride dihydrate&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5.145 g</p><p>Magnesium chloride hexahydrate&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.033 g</p><p>Glucose&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22.000 g</p><p>(S)-Lactic acid&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5.400 g</p><p>&nbsp;</p><p><strong>1000 ml of buffer solution (from the large compartment (B)) contains</strong></p><p>Sodium chloride&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6.450 g</p><p>Sodium hydrogen carbonate&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.090 g</p><p>Potassium chloride&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.314 g</p><p>&nbsp;</p><p><strong>After reconstitution:</strong></p><p>The solutions in the compartments A (250 ml) and B (4750 ml) are mixed to give one reconstituted solution (5000 ml) of which the composition is:</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>mmol/l</strong></p></td><td style="vertical-align:top"><p><strong>mEq/l</strong></p></td></tr><tr><td style="vertical-align:top"><p>Calcium &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ca<sup>2+</sup></p></td><td style="vertical-align:top"><p>1.75</p></td><td style="vertical-align:top"><p>3.50</p></td></tr><tr><td style="vertical-align:top"><p>Magnesium&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mg<sup>2+</sup></p></td><td style="vertical-align:top"><p>0.50</p></td><td style="vertical-align:top"><p>1.00</p></td></tr><tr><td style="vertical-align:top"><p>Sodium&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Na<sup>+</sup></p></td><td style="vertical-align:top"><p>140.00</p></td><td style="vertical-align:top"><p>140.00</p></td></tr><tr><td style="vertical-align:top"><p>Chloride&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cl<sup>-</sup></p></td><td style="vertical-align:top"><p>113.50</p></td><td style="vertical-align:top"><p>113.50</p></td></tr><tr><td style="vertical-align:top"><p>Lactate</p></td><td style="vertical-align:top"><p>3.00</p></td><td style="vertical-align:top"><p>3.00</p></td></tr><tr><td style="vertical-align:top"><p>Hydrogen carbonate&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; HCO<sub>3</sub><sup>-</sup></p></td><td style="vertical-align:top"><p>32.00</p></td><td style="vertical-align:top"><p>32.00</p></td></tr><tr><td style="vertical-align:top"><p>Potassium&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; K<sup>+</sup></p></td><td style="vertical-align:top"><p>4.00</p></td><td style="vertical-align:top"><p>4.00</p></td></tr><tr><td style="vertical-align:top"><p>Glucose</p></td><td style="vertical-align:top"><p>6.10</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Theoretical Osmolarity:</p></td><td colspan="2" style="vertical-align:top"><p>301 mOsm/l</p></td></tr></tbody></table><p><u>&nbsp;</u></p><p><strong>The other ingredients are:</strong> carbon dioxide (E 290), water for injections</p><p>pH of the reconstituted solution: 7.0-8.5</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Prismasol looks like and contents of the pack

Prismasol is presented in a two-compartment bag containing in the smaller compartment A, the electrolyte solution, and in the larger compartment B, the buffer solution. The final reconstituted solution is obtained after breaking the peel seal and mixing both solutions. The reconstituted solution is clear and slightly yellow. Each bag (A+B) contains 5000 ml solution for haemofiltration and haemodialysis. The bag is overwrapped with a transparent film.
Each box contains two bags and a package leaflet.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder:</strong></p><p>Baxter Holding B.V.</p><p>Kobaltweg 49</p><p>3542CE Utrecht</p><p>The Netherland</p><p>&nbsp;</p><p><strong>Manufacturer:</strong></p><p>Bieffe Medital S.p.A.</p><p>Via Stelvio 94</p><p>23035 Sondalo (SO)</p><p>Italy</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in March 2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">یحتوي بریزماسول على المواد الفعالة كلورید الكالسیوم ثنائي ھیدرات، كلورید المغنیسیوم سداسي ھیدرات، مونوھیدرات الجلوكوز، محلول حامض اللاكتیك بنسبة 90 % من المزیج، كلورید الصودیوم، كلورید البوتاسیوم وكربونات ھیدروجین الصودیوم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&rlm; یستخدم بریزماسول في علاج الفشل الكلوي كمحلول لترشیح الدم المستمر أو الترشیح الكیمیائي (كبدیل للسوائل المفقودة من الدم الذي یمر من خلال المرشح) وغسیل الكلى المستمر أو الترشیح الكیمیائي (یتدفق الدم على جانب واحد من غشاء غسیل الكلى بینما یتدفق محلول غسیل الكلى على الجانب الآخر من الغشاء).</p><p dir="RTL">&nbsp;</p><p dir="RTL">یمكن استخدام محلول بریزماسول أیضًا في حالة التسمم بالعقاقیر بالمواد القابلة لغسیل الكلى أو القابلة للترشیح.</p><p dir="RTL">&nbsp;</p><p dir="RTL">یوصف بریزماسول 4 مليمول/لتر بوتاسیوم بشكل خاص للمرضى الذین لدیھم میل إلى فرط بوتاسیوم الدَّم (تركیز عال من البوتاسیوم في الدم).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستخدم بریزماسول 4 مليمول/لتر بوتاسیوم في الحالات التالیة:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسیة تجاه إحدى المواد الفعالة أو أي من المكونات الأخرى (المدرجة في القسم 6)،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التركیز المنخفضللبوتاسیوم في الدم (نقصبوتاسیوم الدم)،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التركیز العالي من البیكربونات في الدم (القلاء الأیضي).</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا یمكن استبعاد وجود مواد مضادة للذرة في بریزماسول.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لا تستخدم بریزماسول في الحالات الثلاث التالیة:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الفشل الكلوي مع فرط الاستقلاب الواضح (زیادة الأیض الھدمي بشكل غیر طبیعي)، إذا كان استخدام المحلول لن یؤدي إلى التغلب على أعراض الیوریة (الأعراض الناجمة عن ارتفاع تركیز الیوریا في الدم) من خلال ترشیح الدم،،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الضغط الشریاني غیر كافٍ للوصول إلى الأوعیة الدمویة،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض تخثر الدم (منع تخثر الدم الشامل)، إذا كان ھناك خطر كبیر من حدوث (نزیف).</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>اﻟﺘﺤﺬﯾﺮات واﻻﺣﺘﯿﺎطﺎت </strong></p><p dir="RTL">ﺗﺤﺪث إﻟﻰ طﺒﯿﺒﻚ أو اﻟﺼﯿﺪﻟﻲ أو اﻟﻤﻤﺮﺿﺔ ﻗﺒﻞ اﺳﺘﺨﺪام بریزماسول.</p><p dir="RTL">&nbsp;</p><p dir="RTL">یجب استخدام المحلول فقط بواسطة أو تحت إشراف طبیب مختص في علاجات الفشل الكلوي باستخدام ترشیح الدم، والترشیح الكیمیائي للدم، وغسیل الكلى المستمر<strong>.</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">ﻗﺒﻞ وأﺛﻨﺎء اﻟﻌﻼج، ﺳﯿﺘﻢ ﻓﺤﺺ ﺣﺎﻟﺔ دﻣﻚ، ﻋﻠﻰ ﺳﺒﯿﻞ اﻟﻤﺜﺎل، ﺳﯿﺘﻢ ﻓﺤﺺ وﻣﺮاﻗﺒﺔ ﺗﻮازن اﻟﻘﻮاﻋﺪ اﻟﺤﻤﻀﯿﺔ وﺗﺮﻛﯿﺰات اﻷﻣﻼح ﻓﻲ اﻟﺪم (اﻹﻟﻜﺘﺮوﻟﯿﺘﺎت)، ﺑﻤﺎ ﻓﻲ ذﻟﻚ ﺟﻤﯿﻊ اﻟﺴﻮاﺋﻞ اﻟﺘﻲ تأخذھا (اﻟﺘﺴﺮﯾﺐ اﻟﻮرﯾﺪي) واﻟﺘﻲ ﺗُﺨﺮﺟﮭﺎ (إﺧﺮاج اﻟﺒﻮل)، ﺣﺘﻰ ﺗﻠﻚ اﻟﺴﻮاﺋﻞ اﻟﺘﻲ ﻻ ﺗﺮﺗﺒﻂ ﻣﺒﺎﺷﺮة ﺑﺎﻟﻌﻼج.</p><p dir="RTL">&nbsp;</p><p dir="RTL">یجب مراقبة تركیز جلوكوز الدم عن كثب، خاصة إذا كنت مصابًا بالسكري.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>اﺳﺘﺨﺪام أدوﯾﺔ أﺧﺮى ﻣﻊ بریزماسول</strong></p><p dir="RTL">أﺧﺒﺮ طﺒﯿﺒﻚ أو اﻟﺼﯿﺪﻟﻲ إذا ﻛﻨﺖ ﺗﺄﺧﺬ، أو أﺧﺬت ﻣﺆﺧﺮًا أو ﻗﺪ ﺗﺄﺧﺬ أدوﯾﺔ أﺧﺮى.</p><p dir="RTL">وذﻟﻚ ﻷن ﻣﺴﺘﻮى ﺗﺮﻛﯿﺰ ﺑﻌﺾ اﻷدوﯾﺔ اﻷﺧﺮى اﻟﺘﻲ ﺗﺘﻨﺎوﻟﮭﺎ ﯾﻘﻞ ﻓﻲ اﻟﺪم أﺛﻨﺎء اﻟﻌﻼج. ﺳﻮف ﯾﻘﺮر اﻟﻄﺒﯿﺐ ﻣﺎ إذا ﻛﺎن ﯾﺠﺐ ﺗﻐﯿﯿﺮ اﻷدوﯾﺔ اﻷﺧﺮى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﻋﻠﻰ وﺟﮫ اﻟﺨﺼﻮص، أﺧﺒﺮ طﺒﯿﺒﻚ إذا ﻛﻨﺖ ﺗﺴﺘﺨﺪم أﯾﺎً ﻣﻤﺎ ﯾﻠﻲ:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﻋﻘﺎر دﯾﺠﯿﺘﺎﻟﯿﺲ (ﻟﻌﻼج ﺑﻌﺾ أﻣﺮاض اﻟﻘﻠﺐ)؛ ﺣﯿﺚ ﯾﺰداد ﺧﻄﺮ ﻋﺪم اﻧﺘﻈﺎم ﺿﺮﺑﺎت اﻟﻘﻠﺐ أو ﺳﺮﻋﺔ ﺿﺮﺑﺎت اﻟﻘﻠﺐ (ﻋﺪم اﻧﺘﻈﺎم ﺿﺮﺑﺎت اﻟﻘﻠﺐ) ﺑﺴﺒﺐ اﻧﺨﻔﺎض ﺗﺮﻛﯿﺰ اﻟﺒﻮﺗﺎﺳﯿﻮم ﻓﻲ اﻟﺪم (ﻧﻘﺺ ﺑﻮﺗﺎﺳﯿﻮم اﻟﺪم).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﻓﯿﺘﺎﻣﯿﻦ د واﻟﻤﻨﺘﺠﺎت اﻟﻄﺒﯿﺔ اﻟﺘﻲ ﺗﺤﺘﻮي ﻋﻠﻰ اﻟﻜﺎﻟﺴﯿﻮم، ﻷﻧﮭﺎ ﺗﺰﯾﺪ ﻣﻦ ﺧﻄﺮ اﻹﺻﺎﺑﺔ ﺑﺰﯾﺎدة ﻛﺎﻟﺴﯿﻮم اﻟﺪم (ﻓﺮط ﻛﺎﻟﺴﯿﻮم اﻟﺪم).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أي مصدر إضافي لكربونات الصودیوم الھیدروجینیة (أو مصدر آخر) قد یزید من خطر زیادة البیكربونات في الدم لدیك (القلاء الأیضي).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عند استخدام السیترات كمضاد للتجلط (كإضافة وقائیة في أجھزة غسیل الكلى)، لأنھا یمكن أن تقلل من مستوى الكالسیوم في البلازما.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اﻟﺤﻤﻞ واﻟﺮﺿﺎﻋﺔ اﻟﻄﺒﯿﻌﯿﺔ</strong></p><p dir="RTL">إذا ﻛﻨﺖِ ﺣﺎﻣﻼً أو ﺗﻘﻮﻣﯿﻦ ﺑﺈرﺿﺎع طﻔﻠﻚ، أو ﺗﻌﺘﻘﺪﯾﻦ أﻧﻚ ﺣﺎﻣﻞ أو ﺗﺨﻄﻄﯿﻦ ﻹﻧﺠﺎب طﻔﻞ، ﻓﺎﺳﺄﻟﻲ طﺒﯿﺒﻚ أو اﻟﺼﯿﺪﻟﻲ ﻟﻠﺤﺼﻮل ﻋﻠﻰ اﻟﻤﺸﻮرة ﻗﺒﻞ ﺗﻨﺎول ھﺬا اﻟﺪواء.</p><p dir="RTL">ﺳﯿﻘﺮر طﺒﯿﺒﻚ ﻣﺎ إذا ﻛﺎن ﯾﺠﺐ إﻋﻄﺎؤك بريزماسول إذا ﻛﻨﺖِ ﺣﺎﻣﻼً أو ﺗﻘﻮﻣﯿﻦ ﺑﺎﻟﺮﺿﺎﻋﺔ اﻟﻄﺒﯿﻌﯿﺔ.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اﻟﻘﯿﺎدة واﺳﺘﺨﺪام اﻵﻻت</strong></p><p dir="RTL">ﻟﻦ ﯾﻜﻮن لبريزماسول أي ﺗﺄﺛﯿﺮ ﻋﻠﻰ اﻟﻘﺪرة ﻋﻠﻰ اﻟﻘﯿﺎدة أو اﺳﺘﺨﺪام اﻵﻻت.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">استخدم ھذا الدواء دائمًا وفقًا لما أخبرك به الطبیب أو الصیدلي. استشر طبیبك أو الصیدلي إذا كنت غیر متأكد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ستعتمد كمیة بریزماسول المستخدمة على حالتك السریریة وتوازن السوائل المستھدف. وبالتالي، فإن حجم الجرعة یخضع لتقدیر</p><p dir="RTL">الطبیب المسؤول.</p><p dir="RTL">&nbsp;</p><p dir="RTL">طریقة إعطاء الدواء: الاستخدام عن طریق الورید في عملیة غسیل الكلى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا ﻛﻨﺖ تعتقد انك ﺗﺴﺘﺨﺪم بريزماسول أﻛﺜﺮ ﻣﻤﺎ ﯾﻨﺒﻐﻲ</strong></p><p dir="RTL">سیتم مراقبة توازن السوائل والتوازن الإلكترولیتي والتوازن الحمضي في الدم لدیك بعنایة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">ﻓﻲ ﺣﺎﻟﺔ اﻟﺠﺮﻋﺔ اﻟﺰاﺋﺪة، وھﻮ أﻣﺮ ﻏﯿﺮ ﻣﺤﺘﻤﻞ، ﺳﯿﻘﻮم اﻟﻄﺒﯿﺐ ﺑﺎﺗﺨﺎذ اﻹﺟﺮاءات اﻟﺘﺼﺤﯿﺤﯿﺔ اﻟﻼزﻣﺔ وﺿﺒﻂ اﻟﺠﺮﻋﺔ.</p><p dir="RTL">ﻗﺪ ﯾﻨﺘﺞ ﻋﻦ اﻟﺠﺮﻋﺔ اﻟﺰاﺋﺪة:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زﯾﺎدة اﻟﺴﻮاﺋﻞ ﻓﻲ اﻟﺪم ﻟﺪﯾﻚ،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارﺗﻔﺎع في ﻣﺴﺘﻮى ﺑﯿﻜﺮﺑﻮﻧﺎت اﻟﺪم (اﻟﻘﻼء اﻷﯾﻀﻲ)،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; و/أو انخفاض في ﻣﺴﺘﻮﯾﺎت اﻷﻣﻼح ﻓﻲ اﻟﺪم (ﻧﻘﺺ ﻓﻮﺳﻔﺎت اﻟﺪم، ﻧﻘﺺ ﺑﻮﺗﺎﺳﯿﻮم اﻟﺪم).</p><p dir="RTL">&nbsp;</p><p dir="RTL">الجرعة الزائدة یمكن أن تؤدي إلى عواقب وخیمة، مثل قصور القلب الاحتقاني، اضطرابات الإلكترولیت أو اضطرابات التوازن</p><p dir="RTL">الحمضي القاعدي في الجسم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﻟﻠﺤﺼﻮل ﻋﻠﻰ إرﺷﺎدات اﻻﺳﺘﺨﺪام، ﯾﺮﺟﻰ اﻻطﻼع ﻋﻠﻰ ﻗﺴﻢ &quot;اﻟﻤﻌﻠﻮﻣﺎت اﻟﺘﺎﻟﯿﺔ ﻣﻮﺟﮭﺔ إﻟﻰ ﻣﺘﺨﺼﺼﻲ اﻟﺮﻋﺎﯾﺔ اﻟﺼﺤﯿﺔ ﻓﻘﻂ&quot;.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا ﻛﺎﻧﺖ ﻟﺪﯾﻚ أي أﺳﺌﻠﺔ أﺧﺮى ﺣﻮل اﺳﺘﺨﺪام ھﺬا اﻟﺪواء، ﻓﺎﺳﺄل طﺒﯿﺒﻚ أو اﻟﺼﯿﺪﻟﻲ أو اﻟﻤﻤﺮﺿﺔ.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">إن ھﺬا اﻟﺪواء، ﻛﻐﯿﺮه ﻣﻦ اﻷدوﯾﺔ، ﻗﺪ ﯾﺘﺴﺒﺐ ﻓﻲ ﺣﺪوث آﺛﺎر ﺟﺎﻧﺒﯿﺔ، وﻟﻜﻦ ﻟﯿﺲ ﺑﺎﻟﻀﺮورة أن ﺗﺤﺪث ھﺬه اﻵﺛﺎر ﻟﻠﺠﻤﯿﻊ.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﺗﻢ اﻹﺑﻼغ ﻋﻦ اﻵﺛﺎر اﻟﺠﺎﻧﺒﯿﺔ اﻟﺘﺎﻟﯿﺔ:</p><p dir="RTL"><strong>ﻏﯿﺮ ﻣﻌﺮوﻓﺔ</strong>: ﻻ ﯾﻤﻜﻦ ﺗﻘﺪﯾﺮ ﻣﻌﺪل اﻟﺘﻜﺮار وﻓﻘًﺎ ﻟﻠﺒﯿﺎﻧﺎت اﻟﻤﺘﻮﻓﺮة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﺗﻐﯿﺮ ﻣﺴﺘﻮﯾﺎت اﻷﻣﻼح ﻓﻲ اﻟﺪم (اﺧﺘﻼل اﻟﺘﻮازن اﻹﻟﻜﺘﺮوﻟﯿﺘﻲ ﻣﺜﻞ ﻧﻘﺺ ﻓﻮﺳﻔﺎت اﻟﺪم، ﻧﻘﺺ ﺑﻮﺗﺎﺳﯿﻮم اﻟﺪم)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رﻓﻊ ﺗﺮﻛﯿﺰ اﻟﺒﯿﻜﺮﺑﻮﻧﺎت ﻓﻲ اﻟﺒﻼزﻣﺎ (اﻟﻘﻼء اﻷﯾﻀﻲ) أو ﺗﻘﻠﯿﻞ ﺗﺮﻛﯿﺰ اﻟﺒﯿﻜﺮﺑﻮﻧﺎت ﻓﻲ اﻟﺒﻼزﻣﺎ (اﻟﺤﻤﺎض اﻷﯾﻀﻲ)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارﺗﻔﺎع أو اﻧﺨﻔﺎض ﺣﺠﻢ اﻟﻤﺎء ﺑﺸﻜﻞ ﻏﯿﺮ طﺒﯿﻌﻲ ﻓﻲ اﻟﺠﺴﻢ (ﻓﺮط أو ﻧﻘﺺ ﺣﺠﻢ اﻟﺪم)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع تركيز الجلوكوز بشكل غير طبيعي في الدم (ارتفاع السكر في الدم)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﻏﺜﯿﺎن</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﻗﻲء</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﺗﺸﻨﺠﺎت اﻟﻌﻀﻼت</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اﻧﺨﻔﺎض ﺿﻐﻂ اﻟﺪم (ھﺒﻮط ﺿﻐﻂ اﻟﺪم)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستويات الكالسيوم الدم (ارتفاع تركيز الكالسيوم في الدم).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">في حالة تعرضك لأي آثار جانبية، تحدث إلى الطبيب أو الصيدلي أو الممرضة. يتضمن ذلك أي آثار جانبية محتملة غير مدرجة في هذه النشرة.</p><p dir="RTL">يمكنك أيضًا الإبلاغ مباشرة عن الآثار الجانبية من خلال: نظام الإبلاغ الوطني الوارد أدناه. بالإبلاغ عن الآثار الجانبية يمكنك المساعدة في توفير مزيد من المعلومات بشأن سلامة هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>السعودية:</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:576px"><tbody><tr><td style="vertical-align:top"><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ والسلامة الدوائية (NPC)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مركز الاتصال التابع لهيئة الغذاء والدواء السعودية: 19999</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &rlm;‫موقع الويب: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول مجلس التعاون الخليجي الأخرى:</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:576px"><tbody><tr><td><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرجاء الاتصال ﺑﺎﻟﻤﺆﺳﺴﺎت واﻟﮭﯿﺌﺎت اﻟﻮطﻨﯿﺔ المختصة ﻓﻲ ﻛﻞ دوﻟﺔ.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ بعيدًا عن رؤية ومتناول الأطفال</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﻻ ﺗﺴﺘﺨﺪم ھﺬا اﻟﺪواء ﺑﻌﺪ ﺗﺎرﯾﺦ اﻧﺘﮭﺎء اﻟﺼﻼﺣﯿﺔ اﻟﻤﺬﻛﻮر ﻋﻠﻰ ظﮭﺮ اﻟﻜﯿﺲ وﻣﻠﺼﻖ اﻟﻌﺒﻮة ﺑﻌﺪ ﻛﻠﻤﺔ EXP (اﻧﺘﮭﺎء اﻟﺼﻼﺣﯿﺔ). ﯾﺸﯿﺮ ﺗﺎرﯾﺦ اﻧﺘﮭﺎء اﻟﺼﻼﺣﯿﺔ إﻟﻰ آﺧﺮ ﯾﻮم ﻣﻦ اﻟﺸﮭﺮ اﻟﻤﺬﻛﻮر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﯾُﺨﺰن ﻓﻲ درﺟﺔ ﺣﺮارة ﻣﻦ 4 درﺟﺎت ﻣﺌﻮﯾﺔ إﻟﻰ 30 درﺟﺔ ﻣﺌﻮﯾﺔ.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﺗﻢ إﺛﺒﺎت اﺳﺘﻘﺮار اﻟﻤﻮاد اﻟﻜﯿﻤﯿﺎﺋﯿﺔ واﻟﻔﯿﺰﯾﺎﺋﯿﺔ اﻟﻤﺴﺘﺨﺪﻣﺔ ﻓﻲ اﻟﻤﺤﻠﻮل اﻟﺬي ﺗﻢ اﺳﺘﻨﺸﺎؤه ﻟﻤﺪة 24 ﺳﺎﻋﺔ ﻋﻨﺪ 22 درﺟﺔ ﻣﺌﻮﯾﺔ. وﻣﻦ وﺟﮭﺔ اﻟﻨﻈﺮ اﻟﻤﯿﻜﺮوﺑﯿﻮﻟﻮﺟﯿﺔ، ﯾﻔﻀﻞ اﺳﺘﺨﺪام اﻟﻤﺴﺘﻨﺸﺄ ﻋﻠﻰ اﻟﻔﻮر. إذا ﻟﻢ ﯾﺘﻢ اﺳﺘﺨﺪام اﻟﻤﺤﻠﻮل ﻓﻮ ًرا، ﻓﺈن أوﻗﺎت وظﺮوف اﻟﺘﺨﺰﯾﻦ ﻗﺒﻞ اﻻﺳﺘﺨﺪام ھﻲ ﻣﺴﺆوﻟﯿﺔ اﻟﻤﺴﺘﺨﺪم وﯾﺠﺐ أﻻ ﺗﺰﯾﺪ ﻋﻦ 24 ﺳﺎﻋﺔ ﺑﻤﺎ ﻓﻲ ذﻟﻚ ﻣﺪة اﻟﻌﻼج.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ﻻ ﺗﻘﻢ ﺑﺎﻟﺘﺨﻠﺺ ﻣﻦ أي أدوﯾﺔ ﻓﻲ ﻣﯿﺎه اﻟﺼﺮف اﻟﺼﺤﻲ أو اﻟﻨﻔﺎﯾﺎت اﻟﻤﻨﺰﻟﯿﺔ. اﺳﺄل اﻟﺼﯿﺪﻟﻲ اﻟﺨﺎص ﺑﻚ ﻋﻦ ﻛﯿﻔﯿﺔ اﻟﺘﺨﻠﺺ ﻣﻦ اﻷدوﯾﺔ اﻟﺘﻲ ﻟﻢ ﺗﻌﺪ ﺗﺴﺘﺨﺪﻣﮭﺎ. ﺳﻮف ﺗﺴﺎﻋﺪ ھﺬه اﻟﺘﺪاﺑﯿﺮ ﻋﻠﻰ ﺣﻤﺎﯾﺔ اﻟﺒﯿﺌﺔ.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ﻣﻜﻮﻧﺎت بريزماسول </strong></p><p dir="RTL">اﻟﻤﻮاد اﻟﻔﻌﺎﻟﺔ ﻗﺒﻞ وﺑﻌﺪ اعادة تركيب اﻟﻤﺤﻠﻮل:</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اﻟﻤﻮاد اﻟﻔﻌﺎﻟﺔ ﻗﺒﻞ اعادة تركيب اﻟﻤﺤﻠﻮل:</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">1000 ﻣﻞ ﻣﻦ اﻟﻤﺤﻠﻮل <strong>ﻣﻦ اﻟﻘﺴﻢ اﻟﺼﻐﯿﺮ (</strong><strong>A</strong><strong>)</strong> ﺗﺤﺘﻮي ﻋﻠﻰ:</p><p dir="RTL">ﻜﺎﻟﺴﯿﻮم ﻛﻠﻮراﯾﺪ ﺛﻨﺎﺋﻲ اﻟﮭﯿﺪرات&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5.145 جرام</p><p dir="RTL">ﻤﻐﻨﯿﺴﯿﻮم ﻛﻠﻮراﯾﺪ ﺳﺪاﺳﻲ اﻟﮭﯿﺪرات&nbsp;&nbsp;&nbsp;&nbsp; 2.033 جرام</p><p dir="RTL">الجلوكوز&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22 جرام</p><p dir="RTL">حمض اللاكتيك&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5.4 جرام</p><p dir="RTL">&nbsp;</p><p dir="RTL">1000 ﻣﻞ ﻣﻦ اﻟﻤﺤﻠﻮل <strong>ﻣﻦ اﻟﻘﺴﻢ الكبير</strong> <strong>(</strong><strong>B</strong><strong>)</strong> ﺗﺤﺘﻮي ﻋﻠﻰ:</p><p dir="RTL">ﺼﻮدﯾﻮم كلورايد&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6.45 جرام</p><p dir="RTL">ﻛﺮﺑﻮﻧﺎت اﻟﺼﻮدﯾﻮم اﻟﮭﯿﺪروﺟﯿﻨﯿﺔ&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.09 جرام</p><p dir="RTL">كلورید البوتاسیوم&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0.314 جرام</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اﻟﻤﻮاد اﻟﻔﻌﺎﻟﺔ بعد اعادة تركيب اﻟﻤﺤﻠﻮل:</strong></p><p dir="RTL">ﯾﺘﻢ ﺧﻠﻂ اﻟﻤﺤﺎﻟﯿﻞ ﻣﻦ اﻟﻘﺴﻢ <strong>A</strong> (250 مللتر) ﻣﻊ اﻟﻤﺤﻠﻮل ﻣﻦ اﻟﻘﺴﻢ <strong>B</strong> (4750 مللتر) ﻟﻌﻤﻞ اﻟﻤﺤﻠﻮل المُعاد تركيبه (5000 مللتر) والذي ﯾﻜﻮن ﺗﺮﻛﯿﺒﮫ ﻛﺎﻟﺘﺎﻟﻲ:</p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&nbsp;</p></td><td style="vertical-align:top"><p dir="RTL"><strong>مليمول/لتر</strong></p></td><td style="vertical-align:top"><p dir="RTL"><strong>مل مكافئ/لتر</strong></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">اﻟﻜﺎﻟﺴﯿﻮم، Ca<sup>2+</sup></p></td><td style="vertical-align:top"><p dir="RTL">1.75</p></td><td style="vertical-align:top"><p dir="RTL">3.5</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">اﻟﻤﻐﻨﯿﺴﯿﻮم، Mg<sup>2+</sup></p></td><td style="vertical-align:top"><p dir="RTL">0.5</p></td><td style="vertical-align:top"><p dir="RTL">1</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">ﺻﻮدﯾﻮم، Na<sup>+</sup></p></td><td style="vertical-align:top"><p dir="RTL">140</p></td><td style="vertical-align:top"><p dir="RTL">140</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">ﻛﻠﻮرﯾﺪ، Cl<sup>-</sup></p></td><td style="vertical-align:top"><p dir="RTL">113.50</p></td><td style="vertical-align:top"><p dir="RTL">113.50</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">اﻟﻼﻛﺘﺎت</p></td><td style="vertical-align:top"><p dir="RTL">3</p></td><td style="vertical-align:top"><p dir="RTL">3</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">كربونات هيدروجين، HCO<sub>3</sub><sup>-</sup></p></td><td style="vertical-align:top"><p dir="RTL">32</p></td><td style="vertical-align:top"><p dir="RTL">32</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">بوتاسيوم، K<sup>+</sup></p></td><td style="vertical-align:top"><p dir="RTL">4</p></td><td style="vertical-align:top"><p dir="RTL">4</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">جلوكوز</p></td><td style="vertical-align:top"><p dir="RTL">6.10</p></td><td style="vertical-align:top"><p dir="RTL">&nbsp;</p></td></tr></tbody></table><p dir="RTL">اﻷﺳﻤﻮﻟﯿﺔ اﻟﻨﻈﺮﯾﺔ: 301 ﻣﻠﻠﻲ أوﺳﻤﻮل/ﻟﺘﺮ.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اﻟﻤﻜﻮﻧﺎت اﻷﺧﺮى ھﻲ</strong>: ﺛﺎﻧﻲ أﻛﺴﯿﺪ اﻟﻜﺮﺑﻮن (E 290) وﻣﺎء ﻟﻠﺤﻘﻦ.</p><p dir="RTL">درجة حموضة المحلول المُعاد تركيبه: 7.0 - 8.5</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ﻛﯿﻒ ﯾﺒﺪو بريزماسول وﻣﺎ ھي ﻣﺤﺘﻮﯾﺎت اﻟﻌﺒﻮة </strong></p><p dir="RTL">ﯾﺄﺗﻲ بریزماسول ﻓﻲ ﻛﯿﺲ مكوّن من ﻗﺴﻤﯿﻦ. يحتوي اﻟﻘﺴﻢ اﻟﺼﻐﯿﺮ (A) على المحلول الإلكتروليتي، و اﻟﻘﺴﻢ الكبير (B) على المحلول المنظم. ﯾﺘﻢ اﻟﺤﺼﻮل ﻋﻠﻰ اﻟﻤﺤﻠﻮل اﻟﻨﮭﺎﺋﻲ المعاد تركيبه ﺑﻌﺪ ﻧﺰع ﺧﺘﻢ اﻹﻏﻼق وﻣﺰج ﻛﻼ اﻟﻤﺤﻠﻮﻟﯿﻦ. ﯾﻜﻮن اﻟﻤﺤﻠﻮل المعاد تركيبه ﺷﻔﺎﻓًﺎ ويميل ﻠﻮنه الى الأصفر الفاتح. ﻛﻞ ﻛﯿﺲ ﺑﮫ ﻗﺴﻤﯿﻦ (A+B) ﯾﺤﺘﻮي ﻋﻠﻰ ﻣﺤﻠﻮل 5000 ﻣللتر ﻟﻼﺳﺘﺨﺪام ﻓﻲ ﺗﻨﻘﯿﺔ اﻟﺪم وﺗﺮﺷﯿﺢ اﻟﺪم و/أو اﻟﻐﺴﯿﻞ اﻟﻜﻠﻮى. اﻟﻜﯿﺲ ﻣﻐﻠﻒ ﺑﻐﻼف رﻗﯿﻖ ﺷﻔﺎف.</p><p dir="RTL">يحتوي ﻛﻞ كرتون ﻋﻠﻰ ﻛﯿﺴﯿﻦ وﻧﺸﺮة واﺣﺪة داﺧﻠﯿﺔ.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>حامل ترخيص التسويق والمصانع</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">حامل ترخيص التسويق:</p><p dir="RTL">Baxter Holding B.V.</p><p>Kobaltweg 49</p><p>3542CE Utrecht</p><p>The Netherland</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتم تصنيعه في:</p><p dir="RTL">Bieffe Medital S.p.A.,</p><p>Via Stelvio 94,</p><p>23035 Sondalo (SO),</p><p>Italy</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة آخر مرة في مارس 2023.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Prismasol 4 mmol/l Potassium solution for haemodialysis/haemofiltration
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Prismasol 4 mmol/l Potassium is presented in a two-compartment bag containing in the smaller compartment A, the electrolyte solution, and in the larger compartment B, the buffer solution. The final reconstituted solution is obtained after breaking the frangible pin or peel seal and mixing both solutions.

BEFORE RECONSTITUTION
1 000 ml of electrolyte solution (small compartment A) contains:
active substances:
Calcium chloride dihydrate	5.145 g
Magnesium chloride hexahydrate	2.033 g
Glucose	22.00 g
(as glucose monohydrate)	
(S)-Lactic acid	5.400 g
(as lactic acid solution 90 %w/w)	

1 000 ml of buffer solution (large compartment B) contains:
active substances:
Sodium chloride	6.45 g
Potassium chloride	0.314 g
Sodium hydrogen carbonate 	3.090 g

                                                          A+B
Calcium chloride, 2 H2O	0.257 g
Magnesium chloride, 6 H2O	0.102 g
Glucose	1.100 g
Lactic acid	0.270 g
Sodium chloride                             6.128 g
Potassium chloride	0.298 g
Sodium hydrogen carbonate          2.936 g

AFTER RECONSTITUTION
1 000 ml of the reconstituted solution contains:

Active substances	mmol/l	mEq/l
Calcium 	Ca2+	1.75	3.50
Magnesium 	Mg2+	0.5	1.0
Sodium 	Na+	140	140
Chloride 	Cl-	113.5	113.5
Lactate	3	3
Hydrogen carbonate	HCO3-	32	32
Potassium 	K+	4	4
Glucose	6.1	
Each litre of the final reconstituted solution corresponds to 50 ml of electrolyte solution A and 950 ml of buffer solution B.

For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for haemodialysis/haemofiltration

Clear reconstituted solution with a slightly yellow colour.



Theoretical Osmolarity: 301 mOsm/l

pH of the reconstituted solution: 7.0–8.5
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prismasol 4 mmol/l Potassium is used in the treatment of renal failure, as substitution solution in haemofiltration and haemodiafiltration and as dialysis solution in continuous haemodialysis or continuous haemodiafiltration.</p><p>&nbsp;</p><p>Prismasol 4 mmol/l Potassium solution may also be used in case of drug poisoning with dialysable or filterable substances.</p><p>&nbsp;</p><p>Prismasol 4 mmol/l Potassium solution is indicated in patients who are normokalaemic.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology:</p><p>The rate at which Prismasol 4 mmol/l Potassium is administered depends on the blood concentration of electrolytes, acid-base balance, fluid balance and overall clinical condition of the patient. The volume of replacement solution and/or dialysate to be administered will also depend on the desired intensity (dose) of the treatment. The solution should be prescribed and administration (dose, infusion rate, and cumulative volume) should be established only by a physician experienced in critical care medicine and CRRT (Continuous Renal Replacement Therapy).</p><p>&nbsp;</p><p>Flow rates for the substitution solution in haemofiltration and haemodiafiltration are:</p><p>Adult:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 500 - 3000 mL/hour</p><p>Flow rates for the dialysis solution (dialysate) in continuous haemodialysis and continuous haemodiafiltration are:</p><p>Adult:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 500 - 2500 mL/hour</p><p>&nbsp;</p><p>Commonly used flow rates in adults are approximately 2000 to 2500 ml/h which correspond to a daily fluid volume of approximately 48 to 60 L.</p><p>&nbsp;</p><p><strong>Special population:</strong></p><p><strong>&nbsp;</strong></p><p><u>Elderly population</u></p><p>Evidence from clinical studies and experience suggests that use in the elderly population is not associated with differences in safety or effectiveness.</p><p><strong>&nbsp;</strong></p><p><strong>Paediatric population:</strong></p><p><strong>&nbsp;</strong></p><p>The range of flow rates for the substitution solution in haemofiltration and haemodiafiltration and for the dialysis solution (dialysate) in continuous haemodialysis are:</p><p>Children (from neonates to adolescents to 18 years): 1000 to 2000 mL/h/1.73 m<sup>2</sup></p><p>Flow rates up to 4000 mL/h/1.73 m<sup>2</sup> may be needed, especially in younger children (&le;10 kg). The absolute flow rate (in mL/h) in the paediatric population should generally not exceed the maximum adult flow rate.</p><p><sup>&nbsp;</sup></p><p>Method of administration:</p><p>Intravenous use and for haemodialysis.</p><p><s>&nbsp;</s></p><p>Prismasol 4 mmol/l Potassium, when used as a substitution solution is administered into the extracorporeal circuit before (pre-dilution) or after the haemofilter or haemodiafilter (post-dilution).</p><p>For further information on the use of the medicinal product see section 6.6 Special precautions for disposal and other handling.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.*

Solution dependent contraindications
•	Hyperkalaemia
•	Metabolic alkalosis.

* Please pay attention that glucose contained in Prismasol may be produced from hydrolysed corn starch and therefore the presence of corn antigen in the finished product, as hypersensitivity reactions, cannot be excluded.

Haemofiltration/- dialysis dependent contraindications
•	Renal failure with pronounced hypercatabolism, if the uraemic symptoms cannot be corrected with haemofiltration,
•	Insufficient arterial pressure in the vascular access,
•	Systemic anticoagulation (high risk of haemorrhage). 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The solution should be used only by, or under the direction of a physician competent in renal failure treatments using haemofiltration, haemodiafiltration and continuous haemodialysis.</p><p>&nbsp;</p><p><strong>Warnings :</strong></p><p>The electrolyte solution <strong>must </strong>be mixed with the buffer solution <strong>before use</strong> to obtain the reconstituted solution suitable for haemofiltration / haemodiafiltration / continuous haemodialysis.</p><p>&nbsp;</p><p>Use only with appropriate extracorporeal renal replacement equipment.</p><p>&nbsp;</p><p>The solution is a potassium-containing solution. The solution should not be used in patients with hyperkalaemia. The serum potassium concentration must be monitored before and during haemofiltration and/or haemodialysis.</p><p>If hyperkalaemia occurs after treatment is initiated, additional sources of potassium influencing blood concentrations should be assessed. When the solution is used as a replacement solution, decrease the infusion rate and confirm that the desired potassium concentration is achieved. If hyperkalaemia does not resolve, stop the infusion promptly.</p><p>&nbsp;</p><p>If hyperkalaemia develops when the solution is used as a dialysate, administration of a potassium-free dialysate may be necessary to increase the rate of potassium removal.</p><p>&nbsp;</p><p>Despite no cases of severe corn hypersensitivity reactions being reported with Prismasol, solutions containing glucose derived from hydrolysed maize starch should not be used in patients with a known allergy to maize or maize products.</p><p>&nbsp;</p><p>The administration must be stopped immediately if any signs or symptoms of a suspected hypersensitivity reaction develop. Appropriate therapeutic countermeasures must be instituted as clinically indicated.</p><p>&nbsp;</p><p>Because the solution contains glucose and lactate hyperglycaemia may develop, especially in diabetic patients. Blood glucose levels should be monitored regularly. If hyperglycaemia develops, administration of glucose-free replacement solution/dialysate may be necessary. Other corrective measures may be needed to maintain desired glycaemic control.</p><p>&nbsp;</p><p>Prismasol 4 mmol/l Potassium contains hydrogen carbonate (bicarbonate), and lactate (a hydrogen carbonate precursor) which can influence the patient&rsquo;s acid&ndash;base balance. If metabolic alkalosis develops or worsens during therapy with the solution, the administration rate may need to be decreased, or the administration stopped.</p><p>&nbsp;</p><p>The use of contaminated haemofiltration and haemodialysis solution may cause sepsis, shock and death.</p><p>&nbsp;</p><p><strong>Special precautions for use:</strong></p><p>Prismasol 4 mmol/l Potassium may be warmed to 37 &deg;C to enhance patient comfort. Warming of the solution prior to use should be done before reconstitution with dry heat only. Solutions should not be heated in water or in a microwave oven. The solution should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not administer unless the solution is clear and the seal is intact.</p><p><s>&nbsp;</s></p><p>Before and during treatment, electrolyte and acid-base balance should be closely monitored throughout the procedure.</p><p>&nbsp;</p><p>Phosphate up to 1.2 mmol/L may be added to the solution. Use sodium phosphate if adding phosphate to the bag. Inorganic phosphate must be substituted in cases of hypophosphataemia.</p><p>&nbsp;</p><p>The patient&rsquo;s haemodynamic status and fluid balance should be monitored throughout the procedure and corrected as needed.</p><p>&nbsp;</p><p><strong>Paediatric population: </strong></p><p>&nbsp;</p><p>There are no specific warnings and precautions when using this medicine for children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The blood concentration of filterable/dialysable drugs may be reduced during treatment. Corresponding corrective therapy should be instituted if necessary to establish the desired blood concentrations for drugs removed during treatment.</p><p>Interactions with other medicaments can be avoided by correct dosage of the solution for haemofiltration and haemodialysis and precise monitoring.</p><p>&nbsp;</p><p>However, the following interactions are conceivable:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The risk of digitalis-induced cardiac arrhythmia is increased during hypokalaemia;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vitamin D and vitamin D analogues, as well as medicinal products containing calcium (e.g. calcium chloride or calcium gluconate used for maintenance of calcium homeostasis, in CRRT patients receiving citrate anticoagulation and calcium carbonate as phosphate binder) can increase the risk of hypercalcaemia;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additional sodium hydrogen carbonate (or other buffer source) contained in the CRRT fluids or in other fluids administered during therapy may increase the risk of metabolic alkalosis;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; When citrate is used as an anticoagulant, it contributes to the overall buffer load and can reduce plasma calcium levels.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy and breastfeeding</u></p><p>There are no adequate data from the use of Prismasol 4 mmol/l Potassium in pregnant or lactating woman. The prescriber should consider the benefit/risk relationship before administering Prismasol 4 mmol/l Potassium to pregnant or breast-feeding woman.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>There are no data available on fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following undesirable effects are reported from post-marketing experience. The table presented below is according to the MedDRA system organ classification (SOC and Preferred Term Level).</p><p>Frequencies: Not known (cannot be estimated from the available data).</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:539px"><tbody><tr><td style="vertical-align:top; width:225px"><p>System Organ Class</p></td><td style="vertical-align:top; width:273px"><p>Preferred Term</p></td><td style="vertical-align:top; width:103px"><p>Frequency</p></td></tr><tr><td rowspan="4" style="vertical-align:top; width:225px"><p>Metabolism and nutrition disorders</p><p>&nbsp;</p></td><td style="vertical-align:top; width:273px"><p>Electrolyte imbalances e.g.:hypophosphataemia</p></td><td style="vertical-align:top; width:103px"><p>Not known</p></td></tr><tr><td style="vertical-align:top; width:273px"><p>Acid-base balance disorders, e.g. metabolic alkalosis</p></td><td style="vertical-align:top; width:103px"><p>Not known</p></td></tr><tr><td style="vertical-align:top; width:273px"><p>Fluid imbalance e.g.: fluid retention, dehydration</p></td><td style="vertical-align:top; width:103px"><p>Not known</p></td></tr><tr><td style="vertical-align:top; width:273px"><p>Hyperglycaemia</p></td><td style="vertical-align:top; width:103px"><p>Not known</p></td></tr><tr><td style="vertical-align:top; width:225px"><p>Vascular disorders</p></td><td style="vertical-align:top; width:273px"><p>Hypotension</p></td><td style="vertical-align:top; width:103px"><p>Not known</p></td></tr><tr><td rowspan="2" style="vertical-align:top; width:225px"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top; width:273px"><p>Nausea</p></td><td style="vertical-align:top; width:103px"><p>Not known</p></td></tr><tr><td style="vertical-align:top; width:273px"><p>Vomiting</p></td><td style="vertical-align:top; width:103px"><p>Not known</p></td></tr><tr><td style="vertical-align:top; width:225px"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top; width:273px"><p>Muscle spasms</p></td><td style="vertical-align:top; width:103px"><p>Not known</p></td></tr><tr><td style="vertical-align:top; width:225px"><p>Investigations</p></td><td style="vertical-align:top; width:273px"><p>Calcium ionized increased</p></td><td style="vertical-align:top; width:103px"><p>Not known</p></td></tr></tbody></table><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed below.</p><p><strong>To report any side effect(s):</strong></p><ul><li><strong>Saudi Arabia:</strong></li></ul><table border="1" cellspacing="0" cellpadding="0" style="width:588px"><tbody><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/ <u>&nbsp;</u>&nbsp;</p></td></tr></tbody></table><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:588px"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Overdose with Prismasol 4 mmol/l Potassium, should not occur if the procedure is carried out correctly and the fluid balance, electrolyte and acid-base balance of the patient are carefully monitored.</p><p>However, overdose could lead to severe consequences, such as congestive heart failure, electrolyte or acid-base disturbances.</p><p>If hypervolaemia or hypovolaemia occur, this should be corrected immediately.</p><p>If electrolyte imbalance and acid-base balance abnormalities (e.g., metabolic alkalosis, hypophosphataemia, hypokalaemia, etc.) occur, stop administration promptly. There is no specific antidote for overdose. The risk can be minimized by close monitoring and adequate supplementation during treatment (see section 4.4).</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Hemofiltrates.</p><p>ATC code: B05ZB</p><p>&nbsp;</p><p><u>Pharmacodynamic effects</u></p><p>Prismasol 4 mmol/l Potassium, solution for haemofiltration and haemodialysis is pharmacologically inactive. The sodium, calcium, magnesium, potassium, chloride ions and glucose are present at concentrations similar to physiological levels in plasma.</p><p>&nbsp;</p><p><u>Mechanism of action</u></p><p>The solution is used to replace water and electrolytes removed during haemofiltration and haemodiafiltration or to serve as a suitable exchange medium for use during continuous haemodiafiltration or continuous haemodialysis.</p><p>Hydrogen carbonate is used as an alkalising buffer.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant.</p><p>The active ingredients are pharmacologically inactive and are present at concentrations similar to physiological plasma levels.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>All the ingredients of the solution are physiological components in animal and human plasma. Toxic effects are not expected at therapeutic doses.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Electrolyte solution (small compartment A):&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Water for injections</p><p>Buffer solution (large compartment B):&nbsp; Water for injections, Carbon dioxide (E290)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this product must not be mixed with other medicinal products.</p><p>It is the responsibility of the physician to judge the incompatibility of an additive medication with the Prismasol 4 mmol/l Potassium solution by checking for eventual colour change and/or eventual precipitation, insoluble complexes or crystals. The Instructions for Use of the medication to be added must be consulted.</p><p>Before adding a drug, verify it is soluble and stable in water at the pH of Prismasol 4 mmol/l Potassium (pH of reconstituted solutions is 7.0 to 8.5).</p><p>The compatible medication must be added to the reconstituted solution and the solution must be administered immediately.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                PVC: 1 year as packaged for sale.
Polyolefin: 18 months as packaged for sale. 

Chemical and physical in-use stability of the reconstituted solution has been demonstrated for 24 hours at +22oC. If not used immediately in-use storage times and conditions prior to use are the responsibility of the user and should not normally be longer than 24 hours including the duration of the treatment.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store between +4&deg;C and +30&deg;C.</p><p>For storage conditions after reconstitution of the medicinal product, see section 6.3.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The container made in Poly(vinyl chloride) (PVC) or polyolefin is a two compartment bag. The 5000 ml bag is comprised of a small compartment (250 ml) and a large compartment (4750 ml). The two compartments are separated by a frangible pin or a peel seal.</p><p>&nbsp;</p><p>The large compartment B is fitted with an injection connector (or spike connector) made of polycarbonate (PC)<strong>, </strong>which is closed with a rubber disc covered by a cap as well as a luer connector (PC) with a frangible pin (PC) or a valve made of silicone rubber for the connection of the bag with a suitable replacement solution&nbsp;line or&nbsp;dialysis line.</p><p>The bag is overwrapped with a transparent overwrap made of multilayer polymer film.</p><p>&nbsp;</p><p>Each two-compartment bag contains 5000 ml.</p><p>Pack size: 2 x 5000 ml in a box</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The electrolyte solution (small compartment A) is added to the buffer solution (large compartment B) after breaking the frangible pin or opening the peel seal immediately before use to obtain the reconstituted solution.</p><p>&nbsp;</p><p>A patient information leaflet with detailed instruction for use is enclosed in the box.</p><p>Aseptic technique should be used throughout the handling and administration to the patient:</p><p>Do not remove unit from overwrap until ready for use.</p><p>&nbsp;</p><p>Use only if the overwrap is not damaged, all seals are intact, frangible pin or peel seal is not broken, and the solution is clear. Press bag firmly to test for any leakage. If leakage is discovered, discard the solution immediately since sterility can no longer be assured.</p><p>&nbsp;</p><p>The large compartment is fitted with an injection port for the possible addition of other necessary drugs after reconstitution of the solution.</p><p>Before adding a substance or medication, verify that it is soluble and stable in Prismasol 4 mmol/l Potassium, and that the pH range is appropriate (pH of reconstituted solution is 7.0 to 8.5).</p><p>Additives may be incompatible. The instructions for use of the medication to be added and other relevant literature must be consulted. After addition, if there is a colour change and/or the appearance of precipitates, insoluble complexes, or crystals, do not use.</p><p>Mix the solution thoroughly when additives have been introduced. The introduction and mixing of additives must always be performed prior to connecting the solution bag to the extracorporeal circuit.</p><p><strong>&nbsp;</strong></p><p>If a frangible pin separates the two compartments of the bag and a frangible pin is located in the luer connector the following instructions for use should be followed:</p><p><strong>I </strong>Remove the overwrap from the bag and the sheet between the folded compartments. Open the seal by breaking the frangible pin between the two compartments of the bag. The frangible pin will remain in the bag.</p><p><strong>II</strong> Make sure all the fluid from the small compartment A is transferred into the large compartment B.</p><p><strong>III</strong> Rinse the small compartment A <strong>twice </strong>by pressing the mixed solution back into the small compartment and then back into the large compartment B.</p><p><strong>IV</strong> When the small compartment A is empty: shake the large compartment B so that contents mix completely.</p><p>The solution is now ready for use.</p><p><strong>V </strong>The dialysis or replacement line may be connected to either of the two access ports.</p><p><strong>V.a</strong> If the luer connector is used, remove the cap and connect the male luer lock on the dialysis or replacement line to the female luer receptor on the bag: tighten. Using thumb and fingers, break the blue frangible pin at its base, and move it back and forth. Do not use a tool. Verify that the pin is completely separated and that the fluid is flowing freely. The pin will remain in the luer port during the treatment. (See figure V.a below)</p><p><strong>V.b</strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If the injection port is used, first remove the snap-off cap. The injection port is a swabbable port. Then introduce the spike through the rubber septum. Verify that the fluid is flowing freely.</p><p>&nbsp;</p><p>If a frangible pin separates the two compartments of the bag and a valve is located in the luer connector the following instructions for use shall be followed:</p><p><strong>I </strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove the over wrap from the bag immediately before use and discard any other packaging materials. Open the seal by breaking the frangible pin between the two compartments of the bag. The frangible pin will remain in the bag.</p><p><strong>II </strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Make sure all the fluid from the small compartment A is transferred into the large compartment B.</p><p><strong>III</strong> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rinse the small compartment A twice by pressing the mixed solution back into the small compartment A and then back into the large compartment B.</p><p><strong>IV</strong> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; When the small compartment A is empty: shake the large compartment B so that the contents mix completely. The solution is now ready for use and the bag can be hung on the equipment.</p><p><strong>V</strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The dialysis or replacement line may be connected to either of the two access ports.</p><p><strong>Va</strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If the luer access is used, remove the cap with a twist and pull motion, and connect the male luer lock on the dialysis or replacement line to the female luer receptor on the bag using a push and twist motion. Ensure that the connection is fully seated and tighten. The connector is now open. Verify that the fluid is flowing freely.</p><p>When the dialysis or replacement line is disconnected from the luer connector, the connector will close and the flow of the solution will stop. The luer port is a needle-less and swabbable port.</p><p><strong>Vb</strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If the injection port is used, first remove the snap-off cap. The injection port is a swabbable port.Then introduce the spike through the rubber septum. Verify that the fluid is flowing freely.</p><p>&nbsp;</p><p>If a peel seal separates the two compartments of the bag and a valve is located in the luer connector the following instructions for use shall be followed:</p><p><strong>I </strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove the overwrap from the bag immediately before use and discard any other packaging materials. Open the seal by holding the small compartment with both hands and squeezing it until an opening is created in the peel seal between the two compartments.</p><p>II &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Push with both hands on the large compartment until the peel seal between the two compartments is entirely open.</p><p><strong>III&nbsp;&nbsp;&nbsp;&nbsp; </strong>Secure complete mixing of the solution by shaking the bag gently. The solution is now ready for use, and can be hung on the equipment.</p><p><strong>IV&nbsp;&nbsp;&nbsp;&nbsp; </strong>The dialysis or replacement line may be connected to either of the two access ports.</p><p><strong>IVa</strong>&nbsp;&nbsp; If the luer access is used, remove the cap with a twist and pull motion, and connect the male luer lock on the dialysis or replacement line to the female luer receptor on the bag using a push and twist motion. Ensure that the connection is fully seated and tighten. The connector is now open. Verify that the fluid is flowing freely.</p><p>When the dialysis or replacement line is disconnected from the luer connector, the connector will close and the flow of the solution will stop. The luer port is a needle-less and swabbable port.</p><p><strong>IVb</strong>&nbsp;&nbsp; If the injection port is used, first remove the snap-off cap. The injection port is a swabbable port. Then introduce the spike through the rubber septum. Verify that the fluid is flowing freely</p><p>&nbsp;</p><p>The reconstituted solution should be used immediately. If not used immediately, the reconstituted solution should be used within 24 hours, including the duration of the treatment, after addition of the electrolyte solution to the buffer solution.</p><p>&nbsp;</p><p>The reconstituted solution is for single use only. Do not use if container is damaged or if solution is not clear. Discard any unused portion.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter Holding B.V.
Kobaltweg 49
3542CE Utrecht
The Netherland
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                March 2013
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>